Provider participation in the Meaningful Use incentive program has increased significantly, but the clinical quality measures being collected suffer from reliability issues and the U.S. Department of Health & Human Services lacks measures to track the progress of the program’s outcomes goals, according to a new report from the Government Accountability Office.
